Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biologics
Biotech
Merck bets up to $1B on Pearl's 'smart' biologics
Pearl Bio has signed onto a major licensing deal with Merck while raising its own series A round.
Max Bayer
Mar 12, 2024 8:00am
Ex-Apple Tree investors launch new $310M fund for biotechs
Feb 7, 2024 6:00am
CSL Behring unveils its largest R&D site, slated to open in 2022
Sep 14, 2022 10:45am
Bain leads $350M bet on oral asthma startup to fund phase 3
Jul 12, 2022 7:00am
J&J adds 2nd molecule to Midatech long-acting injectable pact
Mar 9, 2022 9:05am
Seismic, padded by ex-Pandion C-suite, unveils with $101M
Feb 9, 2022 7:00am